This acquired impairment in the IFN-gamma pathway may help elucidate why certain patients are vulnerable to these intracellular pathogens, even in the absence of genetically inherited immunological deficiencies or evident acquired immunodeficiency. This evidence concerns the gene IFNG and acquired immunodeficiency.